Loading the map…

Manufacture of basic pharmaceutical products · London

Ptgo Sever UK

Ptgo Sever UK Limited

Net liabilitiesActiveLatest figures: 2026Abridged accountsCompany only18 years on the register

Private limited company registered in London, classed under “Manufacture of basic pharmaceutical products” and 1 other activity.

Headline figures

FY to May 2026 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

What the numbers say

1 finding from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£202420252026
Profit after tax—
Turnover
Net assets
Cash
Employees

Every figure for all 3 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet202420252026
Current assets
Creditors due within a year
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year

3 balance-sheet lines and 1 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does Ptgo Sever UK do?

Private limited company registered in London, classed under “Manufacture of basic pharmaceutical products” and 1 other activity.

›How much turnover does Ptgo Sever UK make?

Answered in the full report

›Is Ptgo Sever UK profitable?

Ptgo Sever UK's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Ptgo Sever UK?

Answered in the full report

›Where is Ptgo Sever UK based?

Its registered office is 6 St David'S Square, Westferry Road, London, E14 3WA, in London.

›When was Ptgo Sever UK founded?

Ptgo Sever UK Limited was incorporated on 23 May 2008.

›Is Ptgo Sever UK still trading?

The register lists Ptgo Sever UK Limited as active.